US
QHSLab, Inc.
USAQ · OTC
$0.32 -20.00% (-$0.08)
1M +12.90%
Market Cap $4.81M
P/E Ratio 9.18x
Div. Yield -
ROE 51.21%
Bulios Fair Price
$0.48
50.0% upside
Current Price
$0.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, USAQ is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
93 /100
Cheap P/E 9.18x
EV/EBITDA 6.39x
P/S 1.59x
Growth
100 /100
Growing Rev. growth 29.37%
Book val. growth 177.25%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 66.50%
Net margin 17.37%
Op. margin 2.74%
Quality
70 /100
Excellent ROIC 4.99%
ROE 51.21%
ROA 27.09%
Debt
90 /100
Low Debt/Equity 0.06x
Current ratio 1.82x
Int. coverage 5.29x
Stability
48 /100
Moderate Beta 0.60x
Rev. volatility 19.31%
EPS volatility 73.55%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about USAQ
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Troy James Grogan
Employees
12
Headquarters
West Palm Beach
Upcoming events
17 NOV
Earnings
Upcoming earnings report